Stock & Company Details
Inhibrx Inc $INBX
Price:
N/A
N/A
15M
$1.8B
52 Week High:
N/A
10 Day Average Volume:
N/A
-14.71
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
INBX technical indicators
Latest Inhibrx Inc (INBX) indicator readings as of 2026-08-28.
INBX's 14-day RSI is 73.8, in overbought territory. At $123.41 it is trading 40.6% above its 200-day moving average of $87.77, and above its 50-day average of $94.19. Price sits near the upper Bollinger Band ($71.64 to $126.87). ADX reads 22.6, sitting between trending and range-bound.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integrative approach to research and development to design differentiated therapeutic candidates. The company has four programs in clinical trials, of which three of the programs are for the treatment of various cancers, and one for the treatment of Alpha-1 Antitrypsin Deficiency.
Finance Bot
Ask your questions
Start by typing a question below.
